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Abstract
Background: The time required for radiographic union following femoral fracture increases with
age in both humans and rats for unknown reasons. Since abnormalities in fracture innervation will
slow skeletal healing, we explored whether abnormal mRNA expression of genes related to nerve
cell activity in the older rats was associated with the slowing of skeletal repair.
Methods: Simple, transverse, mid-shaft, femoral fractures with intramedullary rod fixation were
induced in anaesthetized female Sprague-Dawley rats at 6, 26, and 52 weeks of age. At 0, 0.4, 1, 2,
4, and 6 weeks after fracture, a bony segment, one-third the length of the femur, centered on the
fracture site, including the external callus, cortical bone, and marrow elements, was harvested.
cRNA was prepared and hybridized to 54 Affymetrix U34A microarrays (3/age/time point).
Results: The mRNA levels of 62 genes related to neural function were affected by fracture. Of the
total, 38 genes were altered by fracture to a similar extent at the three ages. In contrast, eight
neural genes showed prolonged down-regulation in the older rats compared to the more rapid
return to pre-fracture levels in younger rats. Seven genes were up-regulated by fracture more in
the younger rats than in the older rats, while nine genes were up-regulated more in the older rats
than in the younger.
Conclusions: mRNA of 24 nerve-related genes responded differently to fracture in older rats
compared to young rats. This differential expression may reflect altered cell function at the fracture
site that may be causally related to the slowing of fracture healing with age or may be an effect of
the delayed healing.
Background
Bone formation to bridge the fracture gap following skel-
etal fracture slows with age in both humans [1-6] and rats
[7-9]. While young, 6-week-old rats reach radiographic
union by 4 weeks after femoral fracture, adult, 26-week-
old rats require 10 weeks, and older, 52-week-old rats
need in excess of 6 months [7]. Despite this increased time
to radiographic union with age, there was no increase in
the time of expression of Indian hedgehog or any of the
bone morphogenetic proteins in the fracture callus for
adult rats [10] or for older rats [11,12]. Radiographic
union for adult and older rats occurred well after the time
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of expression of these skeletally active cytokines [10,11].
Except for markers of osteoblast activity and bone matrix
formation, few genes remain up-regulated during the time
period when bone forms to bridge the fracture gap [10-
12].
These earlier studies done with RT-PCR revealed a paucity
of data for genes differentially expressed by age. We had
hypothesized that bone formation to bridge the fracture
gap would be under a negative-feedback control system.
Thus, the genes which stimulate bone formation should
be up-regulated in adult or older rats to attempt to accel-
erate their slower progression of bony healing. This was
not observed in adult [10] or older [11,12] rats. Either
bone formation to bridge the fracture gap is not subject to
negative-feedback control, or the genes up-regulated to
control this bone formation are not those normally
thought of as being involved in skeletal homeostasis. This
suggested the need for a wider search for genes active dur-
ing the fracture reparative process.
In this project, mRNA gene expression was measured by
DNA microarray technology at various time points after
fracture for young, adult, and older rats. The goal was to
identify genes whose expression following fracture was
altered by age. Such genes may either show reduced
expression, if the age-related slowing of healing is caused
by inadequate expression levels, or they may show
enhanced expression, in an attempt to stimulate some
poorly responding pathway. Among the genes which were
differentially expressed at the fracture site with age were
genes related to nerve cell activity.
In this study, we explored whether abnormal mRNA
expression of genes related to nerve cell activity was asso-
ciated with the slowing of skeletal repair in older rats.
Abnormalities in the innervation of the fracture site will
slow skeletal healing clinically [13-15] and experimen-
tally [16-18].
Methods
Rats
Intact female Sprague-Dawley rats (Harlan Sprague-Daw-
ley, Inc., Indianapolis, IN) were purchased at one or six
months of age and housed in our vivarium in pairs until
they were the proper age for experimentation. The rats
were fed Teklad Rodent Diet [W] (#8604, Harlan Teklad,
Madison, WI) and tap water ad libitum. The work was
done in an AAALAC-accredited vivarium under protocols
approved by our Institutional Animal Care and Use
Committee.
Surgery
Intact female Sprague-Dawley rats at 6 (young), 26 (adult)
or 52 (older) weeks of age, weighing 154 ± 11 g (mean ±
SD), 281 ± 25 g, and 330 ± 30 g respectively, were anaes-
thetized with an intraperitoneal injection of ketamine and
xylazine (30 mg and 5 mg/kg body weight respectively) as
described earlier [7,11]. The left knee was shaved,
scrubbed with Betadine Solution (Purdue Frederick,
Stamford, CT), and draped with sterile sheets. A medial
incision was made at the knee, the patella was deflected
laterally and a 1.0 mm hole was drilled into the inter-
condylar notch. An intramedullary rod (1.0 mm diameter,
stainless steel, type 304V, O-SWGX-400, Small Parts,
Miami Lakes, FL) was placed retrograde into the left femur
[11]. The incision was closed with wound clips. A closed
simple transverse mid-diaphyseal femoral fracture was
induced with a Bonnarens and Einhorn device [19]. Ran-
domly selected rats from among those scheduled for sur-
gery were used for 0 time no-fracture sham controls. Rats
were euthanized at 0, 0.4, 1, 2, 4, and 6 weeks after frac-
ture for a total of 6 time points at each of the 3 ages. Six
rats per time point per age group were selected for micro-
array analysis (2 rats/array). Radiographs were made at
fracture, at 1 week after fracture, and at euthanasia. The
femora were rapidly harvested, and one third of the fem-
oral length, centered on the fracture site, was collected.
This contained the fracture callus with associated cortical
bone and marrow and was frozen in liquid nitrogen and
stored at -75 C.
RNA Sample Preparation and Microarray Processing
Samples were prepared as described in the Affymetrix
GeneChip Expression Analysis Technical Manual (copy-
right 2001, Affymetrix, Inc., Santa Clara, CA, Rev. 1, Part
number 701021, http://www.affymetrix.com). The sam-
ple preparation is described here in brief. Total RNA was
extracted from the tissue by TRIzol (Invitrogen Life Tech-
nologies, Carlsbad, CA) with disruption of the tissue in a
Brinkman Polytron homogenizer. RNA from two rats of
the same age and time point was pooled for each microar-
ray sample. Samples with 30 µg RNA were purified on
RNeasy columns by Qiagen (Valencia, CA, P/N 74104)
and then converted to double-stranded cDNA with a
Superscript Double Stranded cDNA Synthesis Kit (Invitro-
gen Life Technologies, P/N 11917-010). The cDNA was
then expressed as biotin-labeled cRNA by in vitro tran-
scription (IVT) with the Enzo RNA Transcript Labeling Kit
(Affymetrix, P/N 900182). Each sample was spiked with
bioB, bioC, bioD, and cre (Affymetrix P/N 900299). The
biotin-labeled cRNA was fragmented non-enzymatically.
The fragmented cRNA was hybridized to 54 Rat U34A
microarrays (Affymetrix P/N 900249) in the Affymetrix
hybridization buffer for 16 hours at 45 C. The hybridized
arrays were washed and stained in the Affymetrix Fluidics
Station 400 to attach fluorescent labels to the biotin, fol-
lowed by biotin-labeled antibody, and then a second
staining with fluorescent labeling of the biotin. Each array
was scanned twice by the Agilent GeneArray ScannerBMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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G2500A (Agilent Technologies, Palo Alto, CA). Three
arrays from three independent samples (six rats) were
done for each age at each time point.
Data Analysis
The Rat U34A GeneChip Microarray has probe sets for
over 8,700 rat genes. Most probe sets have 20 different
probes for the same gene on each array with 20 additional
mismatch controls. The data were analyzed with Affyme-
trix Microarray Suite 5.0 and Affymetrix Data Mining Tool
3.0 software. Microarray Suite was used to scale the mRNA
expression (signal value) of all genes to an average of 500
for each array. For each gene, the software reported a sig-
nal value and a Present/Marginal/Absent call. This latter
algorithm was a statistical comparison of the variation
among the several probe sets for each gene compared to
the noise level and gave a call for each gene as Present,
Marginal, or Absent. The program then compared the sig-
nal value of each gene in the fractured samples against the
signal value of the same gene in the unfractured control
sample. The difference between the two signal levels, rela-
tive to the variability between the multiple probes for each
gene, yielded a probability of change due to chance alone.
Genes with p less than 0.005 were judged significantly dif-
ferent from the same gene in the unfractured sample. This
more conservative p value was employed to minimize
false positive responses.
The Data Mining Tool was used for cluster analysis with
the Self Organizing Map (SOM) algorithm. The data were
clustered on the signal values between 20 and 20,000 with
the maximum/minimum ratio of at least 3.0 and the max-
imum – minimum difference of at least 100. One hun-
dred clusters were specified.
Nerve-related genes were identified by searches for nerve-
related names in the gene descriptions of each gene on the
microarray. This association was confirmed by a review of
the information for that gene in the NetAffx web site http:/
/www.affymetrix.com and in the PubMed database http:/
/www.ncbi.nlm.nih.gov/entrez/query.fcgi. GenBank
accession numbers and names are shown for each gene.
Each graph shows the average ± SEM of the three microar-
rays that were done for each time point for each age. Sig-
nificant changes in gene expression were demonstrated by
t test and linear regression [20].
This report conforms to the MIAME standards of MGED
http://www.mged.org. A copy of the full microarray data
set has been deposited in the NCBI Gene Expression
Omnibus http://www.ncbi.nlm.nih.gov/geo/ as series
GSE594.
Results
Radiology
In all young rats, bone bridged the fracture gap by four
weeks after surgery. By six weeks after fracture, remodeling
was beginning to obscure the fracture site (Fig. 1). In con-
trast, bone bridging in the adult rats progressed more
slowly. The adult rats did have a vigorous periosteal reac-
tion at the site of the fracture and were approaching radi-
ographic union by six weeks after surgery (Fig. 1). In the
older, one-year-old rats, bridging of the fracture gap by
bone progressed the slowest. They had a minimal perio-
steal reaction at six weeks after surgery (Fig. 1).
General results
On each array, on average, 5,200 genes were scored as
absent, and 3,300 as present. Of these, 1,159 were signif-
icantly up-regulated and 928 were significantly down-reg-
ulated at two weeks after fracture in the adult rats of the
first series (see Additional File 1). Up-regulated genes
included cytokines and matrix genes for both cartilage
and bone. Down-regulated genes included genes related
to blood cell synthesis and mitochondrial function.
SOM clusters identified genes up- or down-regulated by
fracture. Most genes affected by fracture followed the
same time course at all three ages. These genes showed
approximately the same peak expression level and
regressed to baseline at about the same time point at all
three ages. Among the genes affected by fracture were a
number of genes associated with nerve cells. These were
selected for more intense analysis.
Similar responses at all three ages
Up-regulated nerve-related genes are shown in Table 1.
Two examples are shown in the upper two graphs in Fig-
ure 2. Both of these genes were significantly up-regulated
from the 0 time control (P < 0.001 by t test for 9 samples
(3 ages × 3 replicates) of 0 time vs. 0.4 week (Fig. 2, top
graph) or vs. 0 time vs. 2 week (Fig. 2, middle graph)).
Other nerve-related genes were down-regulated by frac-
ture at all three ages (Table 2). These regained near normal
activity by six weeks after fracture. An example is shown in
the bottom graph of Figure 2. This gene (TAG-1) had a sig-
nificant down-regulation after fracture (P < 0.001 by t test
for 9 samples of 0 time vs. 0.4 week), followed by a signif-
icant increase at 6 weeks after fracture compared to 0.4
week after fracture (P < 0.001 by t test for 9 samples).
Defects in the older rats
SOM cluster analysis identified three types of defects in
the older rats. In the first type, a number of genes were
down-regulated by fracture at all three ages. However,
while genes in the younger rats were returning to pre-frac-
ture expression levels by six weeks after fracture, there was
less recovery in the older rats. These genes are shown inBMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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Table 3, and three examples of these genes are shown in
Figure 3. All three of these genes had a significantly
decreased mRNA expression levels at 1 week after fracture
compared to 0 time control (P < 0.001 by t test for 9 sam-
ples (3 ages × 3 replicates)). At 4 and 6 weeks after frac-
ture, the young rats showed faster recovery in mRNA
expression than did the older rats for the three genes in
Fig. 3 (P < 0.01 by t tests for 4 and 6 week young vs. 4 and
6 week old).
In the second type of defect, other genes were up-regu-
lated by fracture, but the response was weaker in the older
rats. These genes are shown in Table 4. Three examples are
shown in Figure 4. The broad peaks of the genes in Figure
4 permitted the t test to demonstrate a significantly higher
expression level in the young rats at 1 and 2 weeks after
fracture in comparison to the same time points of older
rats. These comparisons for the three genes in Figure 4
were significant at P < 0.001 (top graph, AF034963), P <
0.02 (middle graph, AB005541) and P < 0.01 (bottom
graph, U09357) for 6 samples per age group (2 time
points pooled for 3 replicates).
In the third type of defect, genes were also up-regulated by
fracture. However, the response was stronger in the older
rats than in the younger rats. These genes are shown in
Table 5, and three examples are shown in Figure 5. The
peak values for these three genes significantly increased
with age by linear regression (P < 0.001 (top graph,
AF030089), P = 0.01 (middle graph, M88469), and P <
0.001 (bottom graph, X89963) for 9 data points (3 ages ×
3 replicates)).
Present/Marginal/Absent calls
For each gene for each array, the Microarray Suite software
reported a statistical decision as to whether the mRNA was
Present, Marginal, or Absent. We have reviewed these calls
for the genes shown in Figures 2,3,4,5. For Figure 2, the
Present/Marginal/Absent calls were: Fig. 2 Top: 53/1/0;
Fig. 2 Middle: 39/2/13; and Fig. 2 Bottom: 0/0/54. For Fig-
ure 3, the calls were: Fig. 3 Top: 45/2/7; Fig. 3 Middle: 7/
0/47; and Fig. 3 Bottom: 32/6/16. For Figure 4, the calls
were: Fig. 4 Top: 0/0/54; Fig. 4 Middle: 0/0/54; and Fig. 4
Bottom: 51/0/3. For Figure 5, the calls were: Fig. 5 Top:
45/1/8; Fig. 5 Middle: 52/0/2; and Fig. 5 Bottom: 54/0/0.
Discussion
In this study, as in our earlier work [7,10-12], the time
required to reach radiographic union after femoral frac-
ture increased with age in the female rat. This slowing of
fracture repair with age is associated with changes in the
mRNA expression of specific genes within the healing
fracture site [10-12]. To study this further, microarray
technology was used to identify additional genes whose
mRNA expression was affected by skeletal fracture.
Radiographs Figure 1
Radiographs. Radiographs of the fractured left femora at 6 
weeks after fracture in rats 6(A), 26(B), and 52(C) weeks old 
at fracture.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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Table 1: Nerve-related genes up-regulated by fracture at all three ages
GenBank Name Reference
Genes related to apoptosis
S67769 Cardiac sodium/calcium exchanger (Slc8a1) [38]
M82824 Leucopus neurofibromatosis protein – type 1 (NF1) [39]
L11319 Signal peptidase complex 18kD [40]
Genes up-regulated by injury
J03624 Galanin (shown in Fig. 2) [41–43]
E12625 Rat novel protein expressed with nerve injury (sterol-C4-methyl oxidase-like) [44]
Genes related to nerve cell differentiation and growth
Z11558 Glia maturation factor beta [45–47]
A03913 Glia-derived neurite-promoting factor (serine (or cysteine) proteinase inhibitor, clade E, member 2) [48,49]
E05646 Hippocampal cholinergic neurostimulating peptide (phosphatidylethanolamine binding protein) [50]
AB011531 MEGF 5, slit homolog 3 [51]
AA924772 Metallothionein 3 [52,53]
AF097593 N-cadherin, Testicular (cadherin 2) [54,55]
AF023087 Nerve growth factor induced factor A (early growth response 1) [56,57]
AI102795 Pleiotrophin (heparin binding growth factor 8, Hbnf, neurite growth promoting factor 1) (Fig. 2) [58–60]
L19180 Receptor-linked protein tyrosine phosphatase type D (protein tyrosine phosphatase, receptor type D) [61]
AF044910 Survival motor neuron [62]
U64689 Synaptotagmin interacting protein zygin II (fasciculation and elongation protein zeta 2) [63]
Other genes
L07281 Carboxypeptidase E [64,65]
U03416 Neuronal olfactomedin-related ER localized protein [66]
U67140 PSD-95/SAP 90 associated protein-4 (disks large-associated protein 4) [67]
M83680 RAB14 (GTPase Rab 14) [68]
AF016247 RTK40 homolog (tyro 10, discordin domain receptor family, member 2) [69]
X65454 SC65 – Synaptonemal complex protein [70]
AJ006855 Synaptojanin 1 [71]
M96601 Taurine transporter (Slc6a6) [72]
U35245 Vacuolar protein sorting homolog r-vps33b [73]
Alternative names are shown in parentheses. References to physiological roles are shown to the right.
Table 2: Nerve-related genes down-regulated by fracture at all three ages
Genbank Name Reference
Genes associated with the growth cone of nerve fibers
M31725 Axonal glycoprotein TAG-1 (Contactin 2) (shown in Fig. 2) [74]
S82649 Neuronal activity-regulated pentraxin (Narp) [75]
X59149 Neural cell adhesion molecule L1 [76–78]
Genes associated with synaptic signaling pathways
L08496 GABA-A receptor delta subunit [79]
S68944 Na+/Cl--dependent neurotransmitter transporter [80]
S76742 Neurotransmitter transporter rB21a (X transporter protein 3) [81]
U39549 Synaptogyrin (synaptogyrin 1) [82]
D28512 Synaptotagmin III (synaptotagmin 3) [83]
AF007758 Synuclein 1 (synuclein alpha) [84]
Other genes
AF081557 Glial cells missing protein homolog (Gcm1, glial cells missing homolog a) [85]
L15305 Glial-derived neurotrophic factor [86]
M24852 Neuron-specific protein PEP-19 (Purkinje cell protein 4) [87]
D17521 Protein kinase C-regulated chloride channel [88]
Data presented as in Table 1.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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More than two-thirds of the detectable genes on the rat
U34A microarray have a change in mRNA expression level
following fracture [21]. Most of these genes were not
known to participate in the healing process of bone before
the advent of microarray technology [21,22]. This reflects
changes in both the types of cells at the fracture site as well
as changes in the activity of the existing cells. Among the
cells affected by fracture are nerve fibers. Protein and
mRNA of genes related to neuronal functioning are found
in intact bone and in the fracture callus [23-29]. Since
proper innervation of the fracture site is needed for
fracture repair clinically [13-15] and experimentally [16-
18], this led to the hypothesis that the age-related slowing
of fracture repair may be related to the abnormal nerve
cell activity at the fracture site.
To evaluate this hypothesis, nerve-related genes were stud-
ied from among the genes present on the Affymetrix Rat
U34A microarray. Genes were identified for which the
mRNA response to femoral fracture was changed in the
older rats compared to the young rats. Three types of
change with age were found:
1. The mRNA expression levels of the genes shown in
Table 3 and Figure 3 were decreased by fracture. While
gene expression in the young rats was approaching pre-
fracture levels by six weeks after fracture, gene expression
showed minimal return to normal in older rats. Genes in
this category were all related to signaling molecules or to
signal receptors (references shown in Table 3).
2. Other nerve-related genes had strong up-regulation
after fracture in young rats but only mild up-regulation in
older rats. These are shown in Table 4 and Figure 4. This
partial loss of function with age was observed in genes
associated with nerve cell differentiation or cell cycle or
Figure 2
mRNA levels of three nerve-related genes affected by frac- ture in young, adult, and older rats Figure 2
mRNA levels of three nerve-related genes affected 
by fracture in young, adult, and older rats. The first 
two genes were up-regulated at all three ages (0.4 week (top 
graph) and 2 weeks (middle graph) exceed 0 time control at 
P < 0.001), while the third gene was down-regulated at all 
three ages (0.4 week significantly less than 0 time control at P 
< 0.001). Rats were 6, 26 and 52 weeks of age at fracture 
respectively. Samples were collected at the indicated times 
after fracture. The 0 time samples were no-fracture controls. 
Each bar is the mRNA expression level for the indicated gene 
for the average ± SEM of three DNA microarrays in arbitrary 
units of fluorescence. mRNA from two rats of the same age 
and time after fracture were pooled for each array. Gene 
identifications are shown with their GenBank accession 
number. Axonal glycoprotein (TAG-1) is also known as con-
tactin 2.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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genes related to synaptic structure (references cited in
Table 4).
3. A third set of genes was increased in mRNA expression
by fracture, but the increase was greater in the older rats.
These are shown in Table 5 and Figure 5. Many of these
Table 3: Nerve-related genes with prolonged down-regulation after fracture in older rats
GenBank Name Reference
L09119 C kinase substrate calmodulin-binding protein (neurogranin) (shown in Fig. 3) [89]
S77867 G coupled protein receptor UHR-1 (G protein coupled receptor 10) [90]
AF109405 GABA-B receptor 2 (G protein-coupled receptor 51) [91]
U08290 Neuronatin alpha (neuronatin) [92]
M15880 Neuropeptide Y (shown in Fig. 3) [93,94]
S56508 Fatty acid coenzyme A ligase, long chain 6 [95]
AF041083 RoBo-1 (Slc11a1) (shown in Fig. 3) [55,96,97]
X86789 Sensory neuron synuclein (gamma-synuclein) [98,99]
Data presented as in Table 1. All genes are related to signals and signal receptors.
Table 4: Nerve-related genes with a greater up-regulation in younger rats
GenBank Name Reference
Genes related to nerve cell differentiation and the cell cycle
X86003 Neuron-derived orphan receptor-2 [100]
AB005540 PCTAIRE 2 [101]
AB005541 PCTAIRE 3 (shown in Fig. 4) [102]
U09357 Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (shown in Fig. 4) [103]
Genes related to the synapse and sensory perception
AI179632 Proton gated cation channel DRASIC [104]
AF034863 Synaptic scaffolding molecule (S-SCAM, activin receptor interacting protein 1) (shown in Fig. 4) [105,106]
S56141 Sodium-dependent neurotransmitter transporter [107]
Data presented as in Table 1.
Table 5: Nerve-related genes with a greater up-regulation in older rats
GenBank Name Reference
Genes related to signals and signal transduction
X74832 Acetylcholine receptor alpha subunit (cholinergic receptor, nicotinic, alpha polypeptide 1) [108]
M16112 Brain type II calcium/calmodulin dependent protein kinase beta subunit [109]
Genes related to cell adhesion
M88469 F-spondin (shown in Fig. 5) [110]
AF060879 Neurocan (chondroitin sulfate proteoglycan 3) [111,112]
U16845 Neurotrimin [113]
M96375 Non-processed neurexin 1-beta (neurexin 1) [114]
X89963 TSP-4 (thrombospondin-4) (shown in Fig. 5) [115–117]
Other genes
AF030089 Activity and neurotransmitter-induced early gene 4 (ania-4) (shown in Fig. 5) [118]
D88250 Serine protease (complement component 1, s subcomponent) [119]
Data presented as in Table 1.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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genes were related to cell adhesion or to cell signal or sig-
nal transduction (references cited in Table 5).
All three classes of genes showed altered expression in the
older rats compared to young rats. We hypothesize that
bone fracture may physically disrupt nerve fibers in bone.
A sub-population of these skeletal nerve fibers may
regrow into the fracture site or regain function at a slower
rate in older rats. This may account for the failure to
recover from low mRNA values for the first group (pro-
longed down-regulation) or the failure to up-regulate
mRNA expression adequately after fracture in the older
rats in the second group (diminished up-regulation).
Other genes in the third group with increased levels of
mRNA after fracture in the older rats may represent
attempts to stimulate nerve regrowth or other processes
that are not responding. This may represent negative-feed-
back-induced up-regulation caused by effector cell resist-
ance. Taken together, these changes in nerve cell function
with age may contribute to the slowing of fracture repair
in older rats. It must be pointed out that the associations
noted here do not necessarily reflect cause and effect. It is
also possible that the delayed re-innervation of the
fracture site is an effect of the delayed healing in the older
rats and not a cause of the delayed healing.
Experimental studies have been done to detect the role of
innervation on fracture healing. Studies of sectioning the
sciatic nerve in concert with tibial fracture have been
reported to speed fracture healing [30-33]. However, sec-
tioning both femoral and sciatic nerves inhibits fracture
healing [18]. Aro et al. [16] have reported mechanorecep-
tors (Pacinian corpuscles) in the periostium of the rat fib-
ula, which, if removed, lead to non-union [17]. Direct
application of nerve growth factor to the fracture site
increases healing in the rat rib [34].
In humans, abnormal bone healing is also associated with
lack of nerve activity at the fracture site. Nagano et al. [13]
have noted scaphoid nonunion in the wrists of patients
with neuroarthropathy from a long-standing nerve palsy.
Santavirta et al. [14] have found a lack of peripheral inner-
vation at the fracture site of noninfected fractures with
delayed union or nonunion of diaphyseal bones. Nord-
Figure 3
mRNA levels of three nerve-related genes with more pro- longed down-regulated after fracture in the older rats Figure 3
mRNA levels of three nerve-related genes with more 
prolonged down-regulated after fracture in the older 
rats. The 1 week values were significantly less than 0 time 
controls for all three graphs (P < 0.001). Note the failure of 
the mRNA activity to return to pre-fracture levels in the 
older rats (4 and 6 week values for young exceeded older rat 
values at P < 0.01). The data are presented as in Figure 2.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
Page 9 of 14
(page number not for citation purposes)
strom et al. [15] have found a lack of stromal innervation
associated with delayed union or pseudoarthrosis in
spondylolysis.
Humans [1-6] show a slowing of fracture healing with
increasing age as do rats [7-9]. The cause of the slowing of
fracture healing with age is not well understood. The fem-
ora of young rats regain normal biomechanical properties
by 4 weeks after fracture, while adults take 12 weeks, and
older rats require in excess of 6 months [7]. This model
presents an opportunity to elucidate novel genes
important to this healing process. The slowing could
reflect a loss of function as some processes essential for
the rapid healing of fractures in young animals are inhib-
ited with age. Alternatively, the slowing of skeletal repair
with age may be caused by partial resistance of the healing
process to stimulation in adult or older individuals. Such
resistance should result in enhanced stimulation by regu-
latory systems to attempt to evoke a healing response.
Both patterns were seen among the genes studied in this
report. These genes are candidates for further study.
These changes with age are not limited to genes related to
neuronal activity. We have also noted similar changes in
genes related to mitochondrial activity [35]. It is likely
that the age-related changes in fracture repair are caused
by failure of several metabolic pathways. Methods, such as
DNA microarrays, which sample many different
biological pathways will be useful in defining these novel,
multi-faceted defects.
The specificity of these changes is seen in the majority of
the nerve-related genes for which the expression pattern
following fracture was unaffected by age. These transcripts
had similar increases or decreases following fracture in the
young, adult, and older rats. These uniform responses
suggest that most metabolic patterns were unaffected by
age. Nerve-related genes similarly up-regulated by femoral
fracture at all three ages were broadly related to differenti-
ation and growth of nerve cells, to known up-regulation
following nerve injury, or to association with apoptosis
(references cited in Table 1). Some of these genes were
slower to return to baseline values in older rats, such as
galanin and TAG-1. In contrast, nerve-related genes
similarly down-regulated by femoral fracture at all three
Figure 4
mRNA levels of three genes related to nerve function and  up-regulated more in young rats than in older rats following  femoral fracture Figure 4
mRNA levels of three genes related to nerve function 
and up-regulated more in young rats than in older 
rats following femoral fracture. The decline with age 
was significant at P < 0.001 (top graph), P < 0.02 (middle 
graph) and P = 0.01 (bottom graph). The data are presented 
as in Figure 2.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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ages were broadly related to the nerve growth cone or to
synaptic signaling pathways (references cited in Table 2).
In this study gene expression was measured by quantifica-
tion of the mRNA level for each gene with microarray
technology. It must be kept in mind that there are other
control systems which influence the protein synthetic rate
and also protein degradation. Protein synthesis will be
low in the absence of mRNA for that gene, but elevated
mRNA levels are not a guarantee that protein levels will
also be elevated for that gene. Changes noted at the mRNA
level will need to be confirmed at the protein and struc-
tural levels. Assignment of the genes studied herein as
nerve-related is made on the basis of currently available
information. Other cell types in the fracture callus may
also express these genes. Histological studies will permit
the association of these genes with specific cell types
within the fracture callus. These experiments are now in
progress.
We have compared mRNA gene expression by microarray
to that measured by reverse transcription – polymerase
chain reaction (RT-PCR)[36]. Good correlation was found
between the two methods if the transcripts were judged
mostly present, the signal level did not approach the
upper limit of the detector, and the probe sets or PCR
primers were from the same region of the gene [36]. Some
other genes, even though most samples were judged
absent, also gave good correlation between the two meth-
ods. These latter genes were at the upper range of the
absent calls and had good precision between samples
[36]. The genes reported herein have the marked variation
in mRNA levels that have been reported previously in frac-
ture samples [10,11] with large changes in expression after
fracture which return to the prefracture levels as healing
progresses. The finding here of moderate signal levels,
good precision among the three samples for each time
point at each age, and a strong response to fracture
indicate the ability of this technology to report changes in
mRNA levels for these genes.
Conclusions
In summary, most genes respond to bone fracture with
altered mRNA gene expression, including genes related to
neuronal functioning. However, a number of these genes
Figure 5
mRNA levels of three genes related to nerve function and  up-regulated more in older rats than in younger rats follow- ing femoral fracture Figure 5
mRNA levels of three genes related to nerve function 
and up-regulated more in older rats than in younger 
rats following femoral fracture. The increase with age 
was significant at P < 0.001 (top graph), P = 0.01 (middle 
graph), and P < 0.001 (bottom graph). The data are pre-
sented as in Figure 2.BMC Musculoskeletal Disorders 2004, 5:24 http://www.biomedcentral.com/1471-2474/5/24
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responded to fracture differently in older rats than in
young rats. Such differential expression with age may
reflect altered cell functioning at the fracture site that may
be related to the slowing of fracture healing in older rats.
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